Last updated on November 2018

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough


Brief description of study

This is a randomized, double-blind, placebo-controlled, crossover, dose escalation study of bradanicline in subjects with chronic cough

Detailed Study Description

This study will have two 21-day treatment periods separated by a 14-day washout period. There will be a 14-day follow-up period.

Clinical Study Identifier: NCT03622216

Contact Investigators or Research Sites near you

Start Over

Study coordinator

Atlantic Research Center, LLC
Ocean Township, NJ United States
4.33miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.